A Web-Based Study of HIV Prevention in the Era of Pre-Exposure Prophylaxis Among Vulnerable HIV-Negative Gay and Bisexual Men, Transmen, and Transwomen Who Have Sex With Men: Protocol for an Observational Cohort Study.
HIV
implementation science
pre-exposure prophylaxis
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
17 Sep 2019
17 Sep 2019
Historique:
received:
14
02
2019
accepted:
05
07
2019
revised:
17
06
2019
entrez:
21
9
2019
pubmed:
21
9
2019
medline:
21
9
2019
Statut:
epublish
Résumé
Gay, bisexual, and other men who have sex with men continue to bear a large burden of the HIV epidemic in the United States and are among the only populations with increasing incidence in recent years. The Together 5000 (T5K) Study aimed to enroll a US-based, racially diverse sample of HIV-negative men, transmen, and transwomen who are not on pre-exposure prophylaxis (PrEP) into an observational cohort to inform the design, implementation, scale-up, and evaluation of HIV prevention programs. We used internet-based strategies to enroll a large, racially diverse national sample of HIV-negative men, transmen, and transwomen aged 16 to 49 years at high risk of HIV acquisition via sexual networking apps. Study participants are contacted every 6 months (in between annual surveys) for a brief survey on HIV testing, HIV diagnosis, and PrEP use (ie, attempts to access, PrEP initiation, and PrEP discontinuation). Participants complete annual self-administered at-home HIV testing and Web-based surveys. Using baseline serologic data and self-reported HIV testing history, we reconstructed a cohort of persons who were HIV negative at 12 months before baseline to estimate HIV incidence leading up to cohort enrollment. The study sample included 8777 participants from all 50 US states, Puerto Rico, and Guam; 50.91% (4468/8777) were persons of color and 25.30% (2221/8777) were young individuals aged 16 to 24 years. Per eligibility criteria, all T5K participants reported having sex with >2 male partners in the 90 days before enrollment, self-reported not having been diagnosed with HIV, and were not actively taking PrEP. In addition, 79.39% (6968/8777) reported >2 insertive condomless anal sex (CAS) acts, 61.02% (5356/8777) reported >1 receptive CAS acts in the past 90 days. Furthermore, most (7525/8777, 85.74%) reported never having taken PrEP. In total, 70.25% (6166/8777) were sent a self-administered at-home HIV test kit and 82.29% (5074/6166) of those sent a kit returned a sample for testing. The HIV incidence rate during the 12-month period leading up to enrollment was estimated to be 2.41 (95% CI 2.02-2.90) per 100 person-years. A large, national, and racially diverse fully Web-based cohort of HIV-negative men, transmen, and transwomen at high risk for HIV seroconversion has successfully been recruited into longitudinal follow-up. This cohort is at high risk for HIV acquisition and can provide important insights related to the real-world uptake, impact, and equity of HIV prevention interventions in the United States. Participants can be invited to participate in trials aimed at testing strategies to improve the uptake of and engagement in these interventions. RR1-10.2196/13715.
Sections du résumé
BACKGROUND
BACKGROUND
Gay, bisexual, and other men who have sex with men continue to bear a large burden of the HIV epidemic in the United States and are among the only populations with increasing incidence in recent years.
OBJECTIVE
OBJECTIVE
The Together 5000 (T5K) Study aimed to enroll a US-based, racially diverse sample of HIV-negative men, transmen, and transwomen who are not on pre-exposure prophylaxis (PrEP) into an observational cohort to inform the design, implementation, scale-up, and evaluation of HIV prevention programs.
METHODS
METHODS
We used internet-based strategies to enroll a large, racially diverse national sample of HIV-negative men, transmen, and transwomen aged 16 to 49 years at high risk of HIV acquisition via sexual networking apps. Study participants are contacted every 6 months (in between annual surveys) for a brief survey on HIV testing, HIV diagnosis, and PrEP use (ie, attempts to access, PrEP initiation, and PrEP discontinuation). Participants complete annual self-administered at-home HIV testing and Web-based surveys. Using baseline serologic data and self-reported HIV testing history, we reconstructed a cohort of persons who were HIV negative at 12 months before baseline to estimate HIV incidence leading up to cohort enrollment.
RESULTS
RESULTS
The study sample included 8777 participants from all 50 US states, Puerto Rico, and Guam; 50.91% (4468/8777) were persons of color and 25.30% (2221/8777) were young individuals aged 16 to 24 years. Per eligibility criteria, all T5K participants reported having sex with >2 male partners in the 90 days before enrollment, self-reported not having been diagnosed with HIV, and were not actively taking PrEP. In addition, 79.39% (6968/8777) reported >2 insertive condomless anal sex (CAS) acts, 61.02% (5356/8777) reported >1 receptive CAS acts in the past 90 days. Furthermore, most (7525/8777, 85.74%) reported never having taken PrEP. In total, 70.25% (6166/8777) were sent a self-administered at-home HIV test kit and 82.29% (5074/6166) of those sent a kit returned a sample for testing. The HIV incidence rate during the 12-month period leading up to enrollment was estimated to be 2.41 (95% CI 2.02-2.90) per 100 person-years.
CONCLUSIONS
CONCLUSIONS
A large, national, and racially diverse fully Web-based cohort of HIV-negative men, transmen, and transwomen at high risk for HIV seroconversion has successfully been recruited into longitudinal follow-up. This cohort is at high risk for HIV acquisition and can provide important insights related to the real-world uptake, impact, and equity of HIV prevention interventions in the United States. Participants can be invited to participate in trials aimed at testing strategies to improve the uptake of and engagement in these interventions.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
RR1-10.2196/13715.
Identifiants
pubmed: 31538945
pii: v8i9e13715
doi: 10.2196/13715
pmc: PMC6754683
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e13715Subventions
Organisme : NIAID NIH HHS
ID : UG3 AI133675
Pays : United States
Organisme : NIMH NIH HHS
ID : K23 MH102118
Pays : United States
Organisme : NIAID NIH HHS
ID : UH3 AI133675
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI124414
Pays : United States
Organisme : NIMH NIH HHS
ID : L30 MH117751
Pays : United States
Informations de copyright
©Denis Nash, Matthew Stief, Caitlin MacCrate, Chloe Mirzayi, Viraj V Patel, Donald Hoover, David W Pantalone, Sarit Golub, Gregorio Millett, Alexa B D’Angelo, Drew Anne Westmoreland, Christian Grov. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 17.09.2019.
Références
J Int AIDS Soc. 2016 Nov 17;19(1):21263
pubmed: 27863535
Ann Epidemiol. 2019 Jul;35:4-11
pubmed: 31182379
Int J Epidemiol. 2002 Oct;31(5):961-7
pubmed: 12435768
JMIR Mhealth Uhealth. 2018 Jun 14;6(6):e10316
pubmed: 29903702
J Clin Epidemiol. 1996 Jan;49(1):15-20
pubmed: 8598506
Ann Epidemiol. 2018 Dec;28(12):841-849
pubmed: 29983236
J Med Internet Res. 2013 Aug 27;15(8):e194
pubmed: 23981905
J Med Internet Res. 2011 May 13;13(2):e38
pubmed: 21571632
J Med Internet Res. 2016 Jun 09;18(6):e142
pubmed: 27283957
PLoS One. 2012;7(6):e39116
pubmed: 22723942
Clin Infect Dis. 2013 Oct;57(8):1164-71
pubmed: 23797289
J Sex Res. 2014;51(4):390-409
pubmed: 24754360
Curr Opin HIV AIDS. 2012 Nov;7(6):579-86
pubmed: 23076123
J Med Internet Res. 2018 May 31;20(5):e173
pubmed: 29853441
J Clin Epidemiol. 2014 Aug;67(8):845-9
pubmed: 24766858
Field methods. 2012 Aug 1;24(3):272-291
pubmed: 23180978
J Med Internet Res. 2018 Jul 04;20(7):e233
pubmed: 29973332